Escalon Medical Corp. announced unaudited consolidated earnings results for the second quarter and six months ended December 31, 2015. For the second quarter of fiscal 2016, consolidated product revenue decreased to $2,989 million from $3,700 million in the year ago period primarily as a result of a decrease of $639,000 in ultrasound products, a decrease of $109,000 in digital imaging and Axis image management systems offset by an increase of $37,000 in surgical products.  For the quarter ended December 31, 2015, the Company reported a net loss of $265,000 or $0.04 per share. This compares to a net loss of $74,089 for the second quarter of fiscal 2015 or $0.01 per share. Loss from operations was $265,117 compared to $76,774 a year ago. Net loss from continuing operations was $265,100 compared to $76,748 a year ago.

For the first six months of fiscal 2016, the Company reported a net loss of $558,292 or $0.07 per share. This compares to a net loss of $533,048 or $0.07 per share for the first six months of the prior fiscal year. Loss from operations was $517,009 compared to $558,329 a year ago. Net loss from continuing operations was $516,944 compared to $558,292 a year ago. Revenue for the period was $5,770,157 compared to $6,329,947 a year ago.